Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of heparin versus enoxaparin for venous thromboembolism after abdominal surgery
IRCT20240923063130N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Oct 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of heparin and enoxaparin in venous thromboembolism (VTE) (2 arms), sponsored by Islamic Azad University. Primary endpoint: Incidence of venous thromboembolism. Started Oct 2024; status: completed.
02
Drugs
heparinenoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20240923063130N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240923063130N1.